NCT05663515 2026-02-12
EXCEED
AstraZeneca
Recruiting
Clinical Trials
13 trialsNCT02157974 2024-06-04
APPLE
University of Colorado, Denver
Phase 2/3 Completed
NCT02664441 2022-05-05
ECHO
Seattle Children's Hospital
Phase 3 Completed
NCT04969627 2022-04-14
Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.
Shengjing Hospital
Phase 4 Completed
NCT00566813 2021-04-06
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
University of Illinois at Chicago
Phase 1/2 Completed
NCT02635386 2021-01-29
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Woman's
Phase 3 Completed
NCT01061775 2019-10-08
Effects of Exenatide on Hypothalamic Obesity
Children's Hospitals and Clinics of Minnesota
Phase 1/2 Completed
NCT03352869 2019-09-11
Research of Exenatide for Overweight/Obese PCOS Patients With IGR
RenJi Hospital
Phase 4 Completed
NCT04029272 2019-07-23
Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
Peking Union Medical College Hospital
Phase 4 Unknown
NCT02860923 2018-10-16
CRANIOEXE
University Hospital, Bordeaux
Phase 3 Completed
NCT01484873 2017-03-03
Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
Vanderbilt University Medical Center
Phase 2 Completed
NCT02475499 2016-03-14
Incretin-based Drugs and Pancreatic Cancer
Canadian Network for Observational Drug Effect Studies, CNODES
Completed
NCT00344851 2007-07-11
Exenatide and Metformin Therapy in Overweight Women With PCOS
Metabolic Center of Louisiana Research Foundation
Phase 2 Completed